EUVIMEDEUVIMED entdecken
Vergleichsstudie

A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease

Alessandro Mantovani, Stefano Bonapace, Riccardo Morandin, Elena Sani, Gianluigi Lunardi, Matteo Salgarello, Giulio Molon, Giovanni Targher

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.104206 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Alessandro Mantovani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di V…. Hauptthemen laut MEDLINE: Ceramides, Coronary Artery Disease, Myocardial Infarction, Decision Support Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Plasma ceramides (Cer) are associated with adverse cardiovascular outcomes in patients with coronary artery disease (CAD). We examined whether a newly developed plasma ceramide-based risk score (CER24 score) performs better than CERT1 risk score in predicting adverse cardiovascular outcomes in patients with known or suspected CAD. METHODS AND RESULTS: We followed 167 ambulatory patients undergoing stress myocardial perfusion scintigraphy (MPS) for clinical reasons for a median of 6 years. For the CER24 risk score calculation, we measured plasma Cer(d16:1/24:1)/Cer(d16:1/24:0), Cer(d18:0/24:1)/Cer(d18:0/24:0), Cer(d18:1/24:1)/Cer(d18:1/24:0), Cer(d18:2/24:1)/Cer(d18:2/24:0), and Cer(d20:1/24:1)/Cer(d20:1/24:0), both before and after stress MPS, using a targeted liquid chromatography-tandem mass spectrometry assay. Pre-stress CER24 risk categories (high vs. low/moderate risk) at baseline were associated with a ∼3-fold higher risk of developing the primary composite outcome (defined as all-cause mortality or nonfatal myocardial infarction) even after adjustment for age, sex, smoking, diabetes, pre-existing CAD, left ventricular ejection fraction, and stress-induced inducible myocardial ischemia on MPS (adjusted-hazard ratio 3.06, 95 %CI 1.63-5.77; p = 0.001). Post-stress CER24 risk categories yielded similar results. CER24 high-risk category performed better than CERT1 high-risk category in predicting the primary composite outcome (AUCs = 0.647 vs. 0.580; p = 0.048). CONCLUSIONS: The CER24 score is associated with a higher risk of the composite outcome and performs better than CERT1 score in predicting the risk of dying or developing nonfatal cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesCoronary Artery DiseaseMyocardial InfarctionDecision Support TechniquesHumansMaleFemaleMiddle AgedRisk AssessmentPredictive Value of TestsAgedPrognosisBiomarkersTime FactorsMyocardial Perfusion ImagingRisk FactorsHeart Disease Risk Factors

Stichwörter der Autor:innen

Cardiovascular risk predictionCeramidesCoronary artery disease

Substanzen

CeramidesBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy. Electronic address: alessandro.mantovani@univr…
  • Division of Cardiology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
  • Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Clinical Analysis Laboratory and Transfusional Medicine, Clinical Pharmacology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
  • Division of Nuclear Medicine, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.
  • Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, VR, Italy.

Zitieren

APA

Mantovani, A., Bonapace, S., Morandin, R., Sani, E., Lunardi, G., Salgarello, M., Molon, G., & Targher, G. (2025). A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104206

Vancouver

Mantovani A, Bonapace S, Morandin R, Sani E, Lunardi G, Salgarello M, et al. A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104206

BibTeX
@article{Mantovani2025,
  author = {Mantovani, Alessandro and Bonapace, Stefano and Morandin, Riccardo and Sani, Elena and Lunardi, Gianluigi and Salgarello, Matteo and Molon, Giulio and Targher, Giovanni},
  title = {A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.104206}
}
Kostenlos starten →